Track topics on Twitter Track topics that are important to you
HENDERSON, Nev., July 21, 2015 (GLOBE NEWSWIRE) -- CipherLoc Corporation (OTCQB:CLOK), a leading provider of Digital Cyber Security solutions (CipherLoc©) announced today that it has entered into a Confidential Consulting Agreement with a leader in Insurance Consulting Industry.
Per the Agreement this private company will provide professional business services and representation of CipherLoc© solutions to the insurance industry, as well as with state insurance regulators, legislatures and Governors.
The much-anticipated collaboration between the two companies is off to a good start, according to Michael DeLaGarza, CEO of CipherLoc. "The goal is to further establish partnerships and sales channels for CipherLoc© products and service to help nationalize our reach and presence in the insurance industries."
The consultant agreement signed on July 1, 2015 between CipherLoc© and the Insurance Consulting Group would assist CipherLoc with the development and distribution of CipherLoc© solutions to the insurance industry.
CipherLoc Corporation's CEO, Michael DeLaGarza commented, "We believe the future of the industry lays in CipherLoc's cyber security Polymorphic Key Progression Algorithmic Cipher Engine solution.
This is the first and only Polymorphic Key Progression Algorithmic Cipher Engine that can be used in commercial, security sensitive applications and is far more secure than any cipher by itself because it is a polymorphic cipher "engine" that changes "on the fly" and has no stored keys in databases.
CipherLoc© is the first of a new generation of advanced, secure and affordable encryption technologies that can be used in commercial, security sensitive applications to eliminate dependence on a single type of cipher to achieve essentially the same security as a One Time Pad (OTP), the most secure cipher known, without all of the disadvantages and additional resources. CipherLoc© is the pinnacle of cipher technology, is infinitely configurable and mathematically provably secure. CipherLoc© can be run as an independent program or added as a module to the program it secures and can be implemented as both a software or a hardware solution or both and is compatible with and significantly enhances current SSL and VPN technologies, but does not require either. Operation is transparent to the end user and no new transmission protocol is needed because CipherLoc© works on the contents of the packets and does not provide a "chosen plaintext" scenario for analysis.
About CipherLoc Corporation
CipherLoc Corporation provides commercial quality, advanced, digital security solutions that comply with governmental regulatory requirements, such as HIPAA and SOX and their CipherLoc© product suite offers both an advanced Polymorphic Cipher Engine and a Polymorphic Hardware Engine.
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company's SEC filings. These risks and uncertainties could cause the company's actual results to differ materially from those indicated in the forward-looking statements.
CONTACT: CipherLoc Corporation 1291 Galleria Drive Suite 200 Henderson, NV 89014 702-818-9011NEXT ARTICLE
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...
Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.